IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lyell Immunopharma Inc

CUSIP: 55083R104 | 263 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Decheng Capital LLC692,050
1.3% of portfolio›$9.7M
StyleTurnoverLocationFiled
Decheng Capital LLC
692,050$9.7M1.3%Agg GrowthVery LowMenlo Park, CA2026-08-14